Full Press Release Details
Novavax Appoints Gail Boudreaux to Board
Md., June 18, 2015 - Novavax, Inc., (Nasdaq: NVAX) a clinical-stage vaccine company focused on the discovery, development
and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the appointment of Gail K. Boudreaux
to its Board of Directors.
are delighted to welcome Gail to Novavax' Board," said Stanley C. Erck, President and CEO of Novavax. "Her outstanding
leadership and business experience will be important to our continued growth and success. Gail's insight on health payors
will be particularly important as we continue to move towards commercialization of our vaccines."
Boudreaux most recently served as the Executive Vice President of UnitedHealth Group from May 2008 until February 2015 and was
the Chief Executive Officer of UnitedHealthcare from January 2011 to November 2014. Her extensive experience includes more
than 30 years of service across a broad spectrum of health care operations. Ms. Boudreaux
is currently a director of Zimmer Holdings, Inc. and Xcel Energy Inc. and a trustee of Dartmouth College.
Ms. Boudreaux holds a Master of Business Administration degree in finance and health care administration from the Columbia Business
School and a bachelor's degree in psychology from Dartmouth College. She has been honored
as one of Fortune's 50 Most Powerful Women in American Business for the last six years and was recognized by Modern Healthcare
as one of the Top 25 Women in Healthcare.
am very happy to be joining Novavax at such an exciting time," said Ms. Boudreaux. "I look forward to helping the company
achieve its goal to develop and deliver safe and effective vaccines to improve global heath."
Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious
diseases. Our recombinant nanoparticles and Matrix-M adjuvant technology are the foundation for groundbreaking innovation
that improves global health through safe and effective vaccines. Additional information about Novavax is available on the
Company's website, novavax.com.
SVP, Chief Financial Officer and
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
Todd Davenport, Ph.D.